Cointime

SpIntellx

company

About

Shaping the Future of Spatially Intelligent Biology

  • 1 - 10

Highlights

Total Funding Amount
$524.99K
Funding Rounds
2
Investors
2
Investments
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$224.99K
Industries
Artificial Intelligence,Biopharma,Biotechnology,Life Science,Machine Learning
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

SpIntellx has the first-mover advantage in Precision Pathology and Spatially Intelligent Biology by applying truly unbiased spatial analytics software powered by explainable AI to decipher the complex cancer biology. SpIntellx’s software solutions have the potential to unlock a plethora of new applications in medicine and research by answering the fundamental question “Why?”, thus revealing the underlying patient-specific disease network biology, across each stage of the drug development, diagnostics, and treatment pipelines.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$524.99K
SpIntellx has raised a total of $524.99K in funding over 2 rounds. Their latest funding was raised on Feb 8, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 8, 2019 Grant $224.99K 1 National Science Foundation — Detail
Sep 10, 2018 Seed $300K 1 Newlin Investment Company — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
SpIntellx has made 1 investments. Their most recent investment was on Nov 28, 2022, when Dwarfs raised €30M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 28, 2022 Dwarfs
Series B €30M Brand Marketing —

Investors

Number of Lead Investors
Number of Investors
2
2
SpIntellx is funded by 2 investors. National Science Foundation and Newlin Investment Company are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Newlin Investment Company Yes Seed
Cointime
เนื้อหา
บริษัท